Emily Luisa Hill is Chief Financial Officer of Replimune Group, Inc.. Currently has a direct ownership of 101,057 shares of REPL, which is worth approximately $1.37 Million. The most recent transaction as insider was on Aug 16, 2024, when has been sold 8,938 shares (Common Stock) at a price of $10.18 per share, resulting in proceeds of $90,988. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 101K
0% 3M change
21.27% 12M change
Total Value Held $1.37 Million

Emily Luisa Hill Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 16 2024
SELL
Open market or private sale
$90,988 $10.18 p/Share
8,938 Reduced 8.13%
101,057 Common Stock
Apr 01 2024
BUY
Grant, award, or other acquisition
-
26,665 Added 19.51%
109,995 Common Stock
Sep 18 2023
BUY
Grant, award, or other acquisition
-
83,330 Added 50.0%
83,330 Common Stock

Also insider at

PTCT
PTC THERAPEUTICS, INC. Healthcare
ELH

Emily Luisa Hill

Chief Financial Officer
South Plainfield, NJ

Track Institutional and Insider Activities on REPL

Follow Replimune Group, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REPL shares.

Notify only if

Insider Trading

Get notified when an Replimune Group, Inc. insider buys or sells REPL shares.

Notify only if

News

Receive news related to Replimune Group, Inc.

Track Activities on REPL